Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines

Magnetic Resonance in Medicine

Volumn 68, Issue 2, 2012, Pages 369-377

  Zietkowski, Dominik ^a   Payne, Geoffrey S ^a   Nagy, Eszter ^b   Mobberley, Margaret A ^c   Ryder, Timothy A ^c   Desouza, Nandita M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

apoptosis; drug resistance; magnetic resonance spectroscopy; mobile lipid resonances; paclitaxel

Indexed keywords

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CONTROLLED DRUG DELIVERY; DROPS; MAGNETIC RESONANCE SPECTROSCOPY; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE; UNSATURATED FATTY ACIDS;

APOPTOTIC CELLS; CELLULAR MORPHOLOGY; CERVICAL CANCER CELLS; CERVICAL CELLS; DRUG RESISTANCE; FATTY ACID SYNTHASE; PACLITAXEL; PHOSPHOLIPASE A2;

LANTHANUM COMPOUNDS;

ACETYL COENZYME A SYNTHETASE; FATTY ACID SYNTHASE; PACLITAXEL; PHOSPHOLIPASE A2; UNSATURATED FATTY ACID;

AGE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID METABOLISM; MITOSIS; MITOSIS INHIBITION; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

EID: 84863825622     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23265     Document Type: Article

References (40)

1. Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L,. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 1996; 88: 1308-1314. (Pubitemid 26301619)
2. Panvichian R, Orth K, Day ML, Day KC, Pilat MJ, Pienta KJ,. Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance. Cancer Res 1998; 58: 4667-4672. (Pubitemid 28480633)
3. Gottesman MM,. Mechanisms of cancer drug resistance. Annu Rev Med 2002; 53: 615-627. (Pubitemid 34177898)
4. May GL, Wright LC, Dyne M, Mackinnon WB, Fox RM, Mountford CE,. Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts. Int J Cancer 1988; 42: 728-733. (Pubitemid 19008916)
5. Aanismaa P, Gatlik-Landwojtowicz E, Seelig A,. P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle. Biochemistry 2008; 47: 10197-10207.
6. Grunicke H, Hofmann J,. Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level. Pharmacol Ther 1992; 55: 1-30. (Pubitemid 23018630)
7. Le Moyec L, Tatoud R, Degeorges A, Calabresse C, Bauza G, Eugene M, Calvo F,. Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line. Cancer Res 1996; 56: 3461-3467. (Pubitemid 26251637)
8. Brisdelli F, Iorio E, Knijn A, Ferretti A, Marcheggiani D, Lenti L, Strom R, Podo F, Bozzi A,. Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells. Biochem Pharmacol 2003; 65: 1271-1280. (Pubitemid 36407779)
9. Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM,. Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br J Cancer 2002; 86: 963-970. (Pubitemid 34271034)
10. Milkevitch M, Shim H, Pilatus U, Pickup S, Wehrle JP, Samid D, Poptani H, Glickson JD, Delikatny EJ,. Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. Biochim Biophys Acta 2005; 1734: 1-12. (Pubitemid 40615215)
11. Schmitz JE, Kettunen MI, Hu DE, Brindle KM,. 1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo. Magn Reson Med 2005; 54: 43-50. (Pubitemid 40898395)
12. Barany M, Venkatasubramanian PN,. Estimation of tissue phospholipids by natural abundance 13C-NMR. Biochim Biophys Acta 1987; 923: 339-346. (Pubitemid 17047575)
13. Hakumaki JM, Kauppinen RA,. 1H NMR visible lipids in the life and death of cells. Trends Biochem Sci 2000; 25: 357-362. (Pubitemid 30497239)
14. Zietkowski D, Davidson RL, Eykyn TR, De Silva SS, Desouza NM, Payne GS. Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted (1)H magnetic resonance spectroscopy. NMR Biomed 2010: 23: 382-390.
15. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR,. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112. (Pubitemid 20213250)
16. Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM,. Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells. Mol Cancer Ther 2006; 5: 187-196.
17. Jerschow A, Muller N,. Suppression of convection artifacts in stimulated-echo diffusion experiments. Double-stimulated-echo experiments. J Magn Reson 1997; 125: 372-375. (Pubitemid 127451901)
18. Jerschow A, Muller N,. Diffusion-separated nuclear magnetic resonance spectroscopy of polymer mixtures. Macromolecules 1998; 31: 6573-6578. (Pubitemid 128567943)
19. Williams PG, Helmer MA, Wright LC, Dyne M, Fox RM, Holmes KT, May GL, Mountford CE,. Lipid domain in cancer cell plasma membrane shown by 1H NMR to be similar to a lipoprotein. FEBS Lett 1985; 192: 159-164. (Pubitemid 16230661)
20. May GL, Wright LC, Holmes KT, Williams PG, Smith IC, Wright PE, Fox RM, Mountford CE,. Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J Biol Chem 1986; 261: 3048-3053. (Pubitemid 17204907)
21. Rosi A, Grande S, Luciani AM, Barone P, Mlynarik V, Viti V, Guidoni L,. (1H) MRS studies of signals from mobile lipids and from lipid metabolites: comparison of the behavior in cultured tumor cells and in spheroids. NMR Biomed 2004; 17: 76-91. (Pubitemid 38477098)
22. Jackowski S,. Cell cycle regulation of membrane phospholipid metabolism. J Biol Chem 1996; 271: 20219-20222. (Pubitemid 26281781)
23. Scaglia N, Chisholm JW, Igal RA,. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS One 2009; 4: e6812.
24. Delikatny E, Jeitner T,. The accumulation of H-1 MR-visible lipid in human glioma cells is independent of the cell cycle. Int J Oncol 1997; 11: 543-550.
25. Holmes KT, Lean CL, Hunt NH, King NJ,. Development of the "activated" high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle. Magn Reson Med 1990; 16: 1-8. (Pubitemid 20353793)
26. Schaeffer BE, Curtis AS,. Effects on cell adhesion and membrane fluidity of changes in plasmalemmal lipids in mouse L929 cells. J Cell Sci 1977; 26: 47-55. (Pubitemid 8245094)
27. Hakumaki JM, Poptani H, Sandmair AM, Yla-Herttuala S, Kauppinen RA,. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat Med 1999; 5: 1323-1327. (Pubitemid 29535613)
28. Griffin JL, Lehtimaki KK, Valonen PK, Grohn OH, Kettunen MI, Yla-Herttuala S, Pitkanen A, Nicholson JK, Kauppinen RA,. Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res 2003; 63: 3195-3201. (Pubitemid 36735872)
29. Barba I, Cabanas ME, Arus C,. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res 1999; 59: 1861-1868. (Pubitemid 29186158)
30. Di Vito M, Lenti L, Knijn A, Iorio E, D'Agostino F, Molinari A, Calcabrini A, Stringaro A, Meschini S, Arancia G, Bozzi A, Strom R, Podo F,. 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim Biophys Acta 2001; 1530: 47-66. (Pubitemid 32123675)
31. Ducharme NA, Bickel PE,. Lipid droplets in lipogenesis and lipolysis. Endocrinology 2008; 149: 942-949.
32. Sathasivam N, Brammah S, Wright LC, Delikatny EJ,. Inhibition of tetraphenylphosphonium-induced NMR-visible lipid accumulation in human breast cells by chlorpromazine. Biochim Biophys Acta 2003; 1633: 149-160. (Pubitemid 37289345)
33. Liu H, Liu Y, Zhang JT,. A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction. Mol Cancer Ther 2008; 7: 263-270. (Pubitemid 351302520)
34. Vazquez-Martin A, Colomer R, Brunet J, Menendez JA,. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin™ by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells. Int J Oncol 2007; 31: 769-776.
35. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E, Fiore C, Xie W, Kung AL, Febbo PG, Subramanian A, Mucci L, Ma J, Signoretti S, Stampfer M, Hahn WC, Finn S, Loda M,. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 2009; 101: 519-532.
36. Zhang Y, Lemasters J, Herman B,. Secretory group IIA phospholipase A(2) generates anti-apoptotic survival signals in kidney fibroblasts. J Biol Chem 1999; 274: 27726-27733.
37. Hennequin C, Giocanti N, Favaudon V,. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Res 1996; 56: 1842-1850.
38. Minagawa Y, Kigawa J, Itamochi H, Kanamori Y, Shimada M, Takahashi M, Terakawa N,. Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways. Jpn J Cancer Res 1999; 90: 1373-1379. (Pubitemid 30032077)
39. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L,. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56: 816-825. (Pubitemid 26055472)
40. Yeung TK, Germond C, Chen X, Wang Z,. The mode of action of taxol: apoptosis at low concentration and necrosis at high concentration. Biochem Biophys Res Commun 1999; 263: 398-404. (Pubitemid 29467208)